Startups
Sunflower Therapeutics is a unique biotechnology start-up focused on dramatically reducing the time and cost to develop and manufacture biologics for patients around the world. With a genetically-optimized host, data-driven process development, and a novel, ‘right-sized’ manufacturing unit, the experienced Sunflower team is creating an efficient, patient-centered, end-to-end drug production platform that we plan to deploy worldwide.
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 20, 2025 | 5 Minutes with A Future Food VC: Alwyn Capital’s Heather Courtney | 4 Mins Read In our new interview series, we quiz future food investors about the solutions that excite them the most, their favourite climate-forward restaurant, and what they look for in successful founders. Heather Courtney is General Par... |
| Oct 8, 2024 | Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions | SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology. With the agreement, SK bioscience expects to improve the immunogenicity and productivity of conjugate vaccines, in... |
| Sunflower Therapeutics | “Sunflower Therapeutics is a biotechnology company delivering next-generation protein manufacturing solutions designed for anyone to use anywhere.” |
Reviews 0
FAQ about Sunflower TX
What has the press written about Sunflower TX?
Parsers VC has collected 4 articles mentioning Sunflower TX, among them “5 Minutes with A Future Food VC: Alwyn Capital’s Heather Courtney” (Feb 20, 2025) and “Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions” (Oct 8, 2024).
Is Sunflower TX still active?
Yes, Sunflower TX is active; its latest activity on Parsers VC dates from Sep 4, 2025.